• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

包括冻疮样狼疮在内的慢性面部结节病:临床描述及拟议的评分系统。

Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems.

作者信息

Baughman Robert P, Judson Marc A, Teirstein Alvin, Lower Elyse E, Lo Kim, Schlenker-Herceg Rozsa, Barnathan Elliot S

机构信息

University of Cincinnati Medical Center, Cincinnati, Ohio 45267, USA.

出版信息

Am J Clin Dermatol. 2008;9(3):155-61. doi: 10.2165/00128071-200809030-00003.

DOI:10.2165/00128071-200809030-00003
PMID:18429644
Abstract

BACKGROUND

Facial lesions including lupus pernio are often a form of chronic cutaneous sarcoidosis.

OBJECTIVE

To evaluate the intra- and inter-observer consistency of objective measures of chronic facial lesions.

METHOD

This was a retrospective study of patients with chronic cutaneous facial lesions including lupus pernio. The lesions were evaluated using two methods.

RESULTS

Of the 25 patients studied, 23 were women and 24 were African American. Lungs (24 patients), sinuses (11 patients), and eyes (7 patients) were also affected. The Sarcoidosis Activity and Severity Index (SASI) characterized individual areas of the face, with 95% of the observations being less than 2 points from the median. A facial SASI total gave a score for the entire face and 93.2% of the scores were within 3 points of the median.

CONCLUSION

Patients with sarcoidosis and chronic facial lesions often have lung, sinus, and eye involvement. The SASI is a reproducible scoring system for chronic facial lesions.

摘要

背景

包括冻疮样狼疮在内的面部病变通常是慢性皮肤结节病的一种形式。

目的

评估慢性面部病变客观测量方法的观察者内和观察者间一致性。

方法

这是一项对包括冻疮样狼疮在内的慢性皮肤面部病变患者的回顾性研究。使用两种方法对病变进行评估。

结果

在研究的25例患者中,23例为女性,24例为非裔美国人。肺部(24例患者)、鼻窦(11例患者)和眼睛(7例患者)也受到影响。结节病活动和严重程度指数(SASI)对面部各个区域进行了表征,95%的观察结果与中位数相差不到2分。面部SASI总分给出了整个面部的评分,93.2%的评分在中位数的3分以内。

结论

结节病和慢性面部病变患者常伴有肺部、鼻窦和眼部受累。SASI是一种用于慢性面部病变的可重复评分系统。

相似文献

1
Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems.包括冻疮样狼疮在内的慢性面部结节病:临床描述及拟议的评分系统。
Am J Clin Dermatol. 2008;9(3):155-61. doi: 10.2165/00128071-200809030-00003.
2
Infliximab therapy for sarcoidosis (lupus pernio).英夫利昔单抗治疗结节病(冻疮样狼疮)。
Br J Dermatol. 2004 Jan;150(1):146-9. doi: 10.1111/j.1365-2133.2004.05769.x.
3
Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents.皮肤结节病的新型疗法:沙利度胺及其他药物的作用
Am J Clin Dermatol. 2004;5(6):385-94. doi: 10.2165/00128071-200405060-00003.
4
Lupus pernio with 2 years of preceding symptomatic gastric sarcoidosis.伴有2年症状性胃结节病病史的冻疮样狼疮。
J Dermatol. 2015 Mar;42(3):330-1. doi: 10.1111/1346-8138.12771. Epub 2015 Jan 9.
5
Short course of infliximab for disfiguring lupus pernio.英夫利昔单抗短疗程治疗毁容性狼疮冻疮。
Eur J Dermatol. 2008 Nov-Dec;18(6):727-9. doi: 10.1684/ejd.2008.0537.
6
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial.英夫利昔单抗治疗慢性皮肤结节病:一项双盲随机临床试验的亚组分析
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 15;32(4):289-95.
7
[Cutaneous sarcoidosis (lupus pernio) with neuroendocrine involvement].[伴有神经内分泌受累的皮肤结节病(冻疮样狼疮)]
Ann Dermatol Venereol. 1991;118(11):829-32.
8
Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.评估皮肤结节病的皮肤结节病活动和形态学工具的可靠性和收敛有效性。
JAMA Dermatol. 2013 May;149(5):550-6. doi: 10.1001/jamadermatol.2013.60.
9
Lupus pernio.冻疮样狼疮
Cutis. 2007 Apr;79(4):289-90.
10
Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease.系统性肉样瘤病患者的特定皮肤损伤:与疾病严重度和慢性度的关系。
Clin Exp Dermatol. 2011 Oct;36(7):739-44. doi: 10.1111/j.1365-2230.2011.04128.x. Epub 2011 Jul 25.

引用本文的文献

1
Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects.结节病的羟氯喹单一疗法:适应症、疗效及副作用。
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Sep 24;41(3):e2024039. doi: 10.36141/svdld.v41i3.15445.
2
Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches.结节病:治疗药物试验及新治疗方法的最新进展
Front Med (Lausanne). 2022 Oct 12;9:991783. doi: 10.3389/fmed.2022.991783. eCollection 2022.
3
The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.
皮肤结节病的演变格局:发病机制的新见解、临床面临的挑战和治疗的新领域。
Am J Clin Dermatol. 2022 Jul;23(4):499-514. doi: 10.1007/s40257-022-00693-0. Epub 2022 May 18.
4
Inter-rater reliability of cutaneous sarcoidosis assessment tools via remote photographic assessment.通过远程照片评估的皮肤结节病评估工具的评分者间信度
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):165-169. doi: 10.36141/svdld.v34i2.5434. Epub 2017 Apr 28.
5
High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosis.高频超声:一种量化皮肤结节病中肉芽肿负荷的新型仪器。
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):136-141. doi: 10.36141/svdld.v34i2.5720. Epub 2017 Aug 25.
6
Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel.患有冻疮样狼疮和英夫利昔单抗诱导性肌炎的结节病患者:对促肾上腺皮质激素凝胶的反应
Respir Med Case Rep. 2015 Nov 19;17:5-7. doi: 10.1016/j.rmcr.2015.11.001. eCollection 2016.
7
Treatment of Sarcoidosis.结节病的治疗。
Clin Rev Allergy Immunol. 2015 Aug;49(1):79-92. doi: 10.1007/s12016-015-8492-9.
8
Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.口服抗分枝杆菌治疗慢性皮肤结节病:一项随机、单盲、安慰剂对照研究。
JAMA Dermatol. 2013 Sep;149(9):1040-9. doi: 10.1001/jamadermatol.2013.4646.
9
Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.评估皮肤结节病的皮肤结节病活动和形态学工具的可靠性和收敛有效性。
JAMA Dermatol. 2013 May;149(5):550-6. doi: 10.1001/jamadermatol.2013.60.
10
A concise review of pulmonary sarcoidosis.肺结节病概述。
Am J Respir Crit Care Med. 2011 Mar 1;183(5):573-81. doi: 10.1164/rccm.201006-0865CI. Epub 2010 Oct 29.